MedPath

A competitive study between mukhadushikahar lepa and gel and its clinical, analytical and pharmaceutical study

Phase 3
Conditions
Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere
Registration Number
CTRI/2019/01/016856
Lead Sponsor
Dr Shweta Helge
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

60 patients of age group 15 to 30 ears with pimples irrespective of gender religion occupation and who are willing to give inform written consent will be included in the study

Exclusion Criteria

hyper pigmentation due to any other reason

Patient with severe skin infection

Other skin disease

Hyper sensitivity t cosmetics

Diagnosed severe systemic disease

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
o of <br/ ><br>Mukhadushika on face at starting day of study.Timepoint: No of <br/ ><br>Mukhadushika on 15 th day of study and after 1 month of study
Secondary Outcome Measures
NameTimeMethod
Discoloration <br/ ><br>1.Discolouration of skin <br/ ><br>involved <br/ ><br>2.strav from lesion <br/ ><br>3.itching at face <br/ ><br>4.pain in lesion <br/ ><br>5.burning in lesion <br/ ><br>Timepoint: Scores will be given to each outcome as 0 to 3
© Copyright 2025. All Rights Reserved by MedPath